The U.S. IPO market cleared $4.2 billion across nine deals in the week ending April 11, the largest volume in a single week since November 2021. The rush came as issuers moved to lock in allocations before SpaceX's anticipated direct listing, expected to absorb $15-20 billion in institutional demand when it prices in late Q2.

Three biotechs, two software platforms, and four industrial sponsors priced at or above range. CoreWeave, the GPU infrastructure play backed by Magnetar and NVentures, raised $1.1 billion at $38 per share, a 12% premium to its February private round. Klarna, the Swedish buy-now-pay-later platform, priced its ADR at $46, valuing the company at $14.6 billion—still 55% below its 2021 peak but 22% above its July 2023 down round. The median first-day pop across the cohort was 8.4%, suggesting disciplined pricing rather than desperation.

The timing reflects three converging factors. Treasury yields have held below 4.35% for six consecutive weeks, the longest stable window since March 2024. The VIX traded below 15 for nineteen straight sessions, a threshold institutional desks require before committing to new equity. And allocators, flush with $387 billion in dry powder across U.S. equity funds as of March 31, are pricing in a Federal Reserve that holds rates through September. Sponsors who delayed listings in Q1 are now moving—seven of the nine deals this week had filed S-1s before December and waited.

The SpaceX effect is real. Three банкс confirmed that allocators have begun reserving capital for the Musk offering, creating a deadline for smaller issuers to secure commitments. SpaceX is expected to list via direct offering rather than traditional IPO, with demand already oversubscribed at a $180 billion private valuation. Sponsors pricing after Memorial Day will compete directly with that gravitational pull. The result: a front-loaded calendar. Sixteen companies are now queued to price by May 23, with aggregate proceeds targeting $8.7 billion.

Watch three follow-on signals. First, the synthetic forward rate on CoreWeave options—if vol sellers price in durability, the IPO window widens. Second, the Klarna ADR discount to NAV—if it tightens below 3% within thirty days, European fintechs will follow. Third, the Renaissance IPO ETF's $680 million in weekly inflows, the highest since January 2022. Sustained flows above $400 million per week would validate the reopening.

The window is open, but it is not patient. Nine deals in five days does not signal exuberance—it signals urgency. Allocators are pricing now because they expect the market to tighten by June, not because they expect it to improve.